Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ERAS protocol aims to cut opioid use in kidney transplants

NCT ID NCT06997016

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study tests whether an Enhanced Recovery After Surgery (ERAS) protocol can reduce the need for strong painkillers after a kidney transplant from a living donor. Sixty adult participants will receive a carbohydrate drink, Tylenol, gabapentin, a local numbing injection, and early walking. Researchers will compare their pain scores and narcotic use to past patients who did not follow this protocol.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Baylor Scott & White All Saints Medical Center

    Fort Worth, Texas, 76104, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

carbohydrate drink, acetaminophen, gabapentin, bupivacaine, and early ambulation

What this could lead to

If it works, this could offer a standard way to manage pain after kidney transplant with fewer narcotics.

What could go wrong

This is a small, single-center study with only 60 participants, so results may not apply to all patients. The protocol involves multiple steps, and some may not tolerate them.

Conditions

The condition(s) this trial relates to.

end stage renal failure Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.